Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11605744 | 0.85 | PTPN1 (0.31) | — | |
| SCHEMBL17972599 | 0.84 | KDM4E (0.35) | CA1CA2CA9CYP1A2CYP2C9 | |
| SCHEMBL431960 | 0.81 | CYP1A2 (0.38) | CA1CA2CA9CYP1A2CYP2C9 | |
| SCHEMBL11562674 | 0.80 | TDP1 (0.41) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL5070407 | 0.79 | CA1 (0.35) | CA1CA2CA9CYP1A2CYP2C9 | |
| SCHEMBL10403522 | 0.79 | CA1 (0.35) | CA1CA2CA9CYP1A2CYP2C9 | |
| SCHEMBL9513161 | 0.79 | CA1 (0.35) | CA1CA2CA9CYP1A2CYP2C9 | |
| SCHEMBL11602981 | 0.77 | PTK2B (0.44) | MEN1LMNAMAPTHPGDTSHR | |
| SCHEMBL11013172 | 0.77 | FABP3 (0.43) | CYP1A2CYP2C9HIF1AALDH1A1LMNA | |
| SCHEMBL131595 | 0.77 | ABCB11 (0.41) | CA1CA2CA9CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11808750-B2 | Solid-phase sampling device and methods for point-source sampling of polar organic analytes | BATTELLE SAVANNAH RIVER ALLIANCE, LLC (US) | 2023-11-07 | — | — | US | disclosed |
| EP-3626702-B1 | CARBONATE DERIVATIVE PRODUCTION METHOD | UNIV KOBE NAT UNIV CORP (JP) | 2023-02-15 | — | — | EP | disclosed |
| CN-110637006-B | Process for producing carbonate derivative | 国立大学法人神户大学 | 2022-05-24 | — | — | CN | disclosed |
| US-11130728-B2 | Carbonate derivative production method | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2021-09-28 | — | — | US | disclosed |
| US-11022593-B2 | Solid phase sampling device and methods for point-source sampling of polar organic analytes | SAVANNAH RIVER NUCLEAR SOLUTIONS, LLC (US) | 2021-06-01 | — | — | US | disclosed |
| US-20200132653-A1 | SOLID PHASE SAMPLING DEVICE AND METHODS FOR POINT-SOURCE SAMPLING OF POLAR ORGANIC ANALYTES | BATTELLE SAVANNAH RIVER ALLIANCE, LLC | 2020-04-30 | — | — | US | disclosed |
| EP-3626702-A1 | CARBONATE DERIVATIVE PRODUCTION METHOD | National University Corporation Kobe University (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-20200079723-A1 | CARBONATE DERIVATIVE PRODUCTION METHOD | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2020-03-12 | — | — | US | disclosed |
| CN-110637006-A | Process for producing carbonate derivative | 国立大学法人神户大学 | 2019-12-31 | — | — | CN | disclosed |
| US-9951179-B2 | Cyclic carbonate monomers and ring opened polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2018-04-24 | — | — | US | disclosed |
| US-6143917-A | FROM A DIARYL CARBONATE AND AN AMINE COMPOUND HAVING AT LEAST ONE HYDROGEN ATOM LOCATED AT AN N-POSITION UNDER MODERATE CONDITIONS AT A HIGH REACTION RATE WITH A HIGH SELECTIVITY AND WITH A HIGH YIELD | UBE INDUSTRIES, LTD. (JP) | 2000-11-07 | — | — | US | disclosed |
| US-6063922-A | Carbamate functional 1,3,5-triazines | CYTEC TECHNOLOGY CORP. (US) | 2000-05-16 | — | — | US | disclosed |
| EP-0976739-A2 | A Process for the preparation of 1,3,5-triazine carbamates, at least biscarbimate functional 1,3,5-triazines as well as use of 1,3,5-triazine carbamates | CYTEC TECHNOLOGY CORP. (US) | 2000-02-02 | — | — | EP | disclosed |
| EP-0902014-A1 | PROCESS FOR PRODUCING ARYL CARBAMATES | UBE INDUSTRIES LIMITED (JP) | 1999-03-17 | — | — | EP | disclosed |
| US-5792866-A | Process for the preparation of 1,3,5-triazine carbamates from amino 1,3,5-triazines and organic carbonates | CYTEC TECHNOLOGY CORPORATION (US) | 1998-08-11 | — | — | US | disclosed |
| US-5705641-A | Process for the preparation of 1,3,5-triazine carbamates from amino-1,3,5-triazines and organic carbonates | CYTEC TECHNOLOGY CORP. (US) | 1998-01-06 | — | — | US | disclosed |
| EP-0624577-A1 | Process for the preparation of 1,3,5-triazine carbamates, at least biscarbamate functional 1,3,5-triazines and their use as crosslinkers | CYTEC TECHNOLOGY CORP. (US) | 1994-11-17 | — | — | EP | disclosed |
| US-4530933-A | 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-07-23 | — | — | US | disclosed |
| US-3936452-A | Process of producing pyrimidyl thiocarbonates | NITTO BOSEKI CO., LTD. (JA) | 1976-02-03 | — | — | US | disclosed |
| US-3932375-A | PROTECTING GROUPS | NITTO BOSEKI CO. LTD. (JA) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200079723-A1 | CARBONATE DERIVATIVE PRODUCTION METHOD | CA4, CA14, CA3 | CA1 12/4885CA2 4/4885CA9 6/4885 |
| US-11130728-B2 | Carbonate derivative production method | CA4, CA14, CA3 | CA1 12/4885CA2 4/4885CA9 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.